Nov 21, 2025 • Zacks Commentary
NEUTRAL
Implied Volatility Surging for International Flavors Stock Options
Investors need to pay close attention to IFF stock based on the movements in the options market lately.
Nov 17, 2025 • Benzinga
NEUTRAL
Hedge Fund Billionaire Carl Icahn's Q3: The Activist Goes Defensive, Dumps A Disaster, And Loads Up On EchoStar - Southwest Gas Hldgs ( NYSE:SWX ) , Icahn Enterprises ( NASDAQ:IEP ) , Centuri Holdings ( NYSE:CTRI ) , Intl Flavors & Fragrances ( NYSE:IFF )
Activist hedge fund billionaire Carl Icahn may be 89, but his portfolio is moving like it's on an energy drink. The billionaire activist's latest 13F filing shows a $9.14 billion book in Q3 that looks unmistakably Icahn: concentrated, contrarian and packed with companies that most hedge funds ...
Nov 05, 2025 • Zacks Commentary
NEUTRAL
International Flavors Earnings Beat Estimates in Q3, Sales Dip Y/Y
IFF tops Q3 earnings estimates despite lower sales, as solid Scent and Taste growth help offset broader softness.
Nov 03, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Hecla Mining to Report Q3 Results: What's in the Cards for the Stock?
HL's Q3 results are set to shine, gaining on the back of higher metal prices through the quarter.
Nov 03, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
B2Gold Gets Ready to Report Q3 Earnings: Here's What to Expect
BTG is set to post Q3 results, with earnings projected to jump to 15 cents per share as higher gold prices and Fekola gains drive the quarterly performance.
Nov 03, 2025 • Benzinga
SOMEWHAT-BULLISH
Kailera Therapeutics Appoints Frank Clyburn to Board of Directors
WALTHAM, Mass. and SAN DIEGO, Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a differentiated, late-stage portfolio of next-generation therapies for the treatment of obesity, today announced the appointment of Frank ...